Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer.
Hotta K, Takigawa N, Kiura K, Tabata M, Umemura S, Ogino A, Uchida A, Bessho A, Segawa Y, Shinkai T, Nogami N, Harita S, Okimoto N, Ueoka H, Tanimoto M.
Hotta K, et al. Among authors: tabata m.
Anticancer Res. 2005 May-Jun;25(3c):2429-34.
Anticancer Res. 2005.
PMID: 16080470
Free article.
Clinical Trial.